Cargando…
Predicting active site residue annotations in the Pfam database
BACKGROUND: Approximately 5% of Pfam families are enzymatic, but only a small fraction of the sequences within these families (<0.5%) have had the residues responsible for catalysis determined. To increase the active site annotations in the Pfam database, we have developed a strict set of rules,...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025603/ https://www.ncbi.nlm.nih.gov/pubmed/17688688 http://dx.doi.org/10.1186/1471-2105-8-298 |
_version_ | 1782136795715076096 |
---|---|
author | Mistry, Jaina Bateman, Alex Finn, Robert D |
author_facet | Mistry, Jaina Bateman, Alex Finn, Robert D |
author_sort | Mistry, Jaina |
collection | PubMed |
description | BACKGROUND: Approximately 5% of Pfam families are enzymatic, but only a small fraction of the sequences within these families (<0.5%) have had the residues responsible for catalysis determined. To increase the active site annotations in the Pfam database, we have developed a strict set of rules, chosen to reduce the rate of false positives, which enable the transfer of experimentally determined active site residue data to other sequences within the same Pfam family. DESCRIPTION: We have created a large database of predicted active site residues. On comparing our active site predictions to those found in UniProtKB, Catalytic Site Atlas, PROSITE and MEROPS we find that we make many novel predictions. On investigating the small subset of predictions made by these databases that are not predicted by us, we found these sequences did not meet our strict criteria for prediction. We assessed the sensitivity and specificity of our methodology and estimate that only 3% of our predicted sequences are false positives. CONCLUSION: We have predicted 606110 active site residues, of which 94% are not found in UniProtKB, and have increased the active site annotations in Pfam by more than 200 fold. Although implemented for Pfam, the tool we have developed for transferring the data can be applied to any alignment with associated experimental active site data and is available for download. Our active site predictions are re-calculated at each Pfam release to ensure they are comprehensive and up to date. They provide one of the largest available databases of active site annotation. |
format | Text |
id | pubmed-2025603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20256032007-10-16 Predicting active site residue annotations in the Pfam database Mistry, Jaina Bateman, Alex Finn, Robert D BMC Bioinformatics Database BACKGROUND: Approximately 5% of Pfam families are enzymatic, but only a small fraction of the sequences within these families (<0.5%) have had the residues responsible for catalysis determined. To increase the active site annotations in the Pfam database, we have developed a strict set of rules, chosen to reduce the rate of false positives, which enable the transfer of experimentally determined active site residue data to other sequences within the same Pfam family. DESCRIPTION: We have created a large database of predicted active site residues. On comparing our active site predictions to those found in UniProtKB, Catalytic Site Atlas, PROSITE and MEROPS we find that we make many novel predictions. On investigating the small subset of predictions made by these databases that are not predicted by us, we found these sequences did not meet our strict criteria for prediction. We assessed the sensitivity and specificity of our methodology and estimate that only 3% of our predicted sequences are false positives. CONCLUSION: We have predicted 606110 active site residues, of which 94% are not found in UniProtKB, and have increased the active site annotations in Pfam by more than 200 fold. Although implemented for Pfam, the tool we have developed for transferring the data can be applied to any alignment with associated experimental active site data and is available for download. Our active site predictions are re-calculated at each Pfam release to ensure they are comprehensive and up to date. They provide one of the largest available databases of active site annotation. BioMed Central 2007-08-09 /pmc/articles/PMC2025603/ /pubmed/17688688 http://dx.doi.org/10.1186/1471-2105-8-298 Text en Copyright © 2007 Mistry et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Database Mistry, Jaina Bateman, Alex Finn, Robert D Predicting active site residue annotations in the Pfam database |
title | Predicting active site residue annotations in the Pfam database |
title_full | Predicting active site residue annotations in the Pfam database |
title_fullStr | Predicting active site residue annotations in the Pfam database |
title_full_unstemmed | Predicting active site residue annotations in the Pfam database |
title_short | Predicting active site residue annotations in the Pfam database |
title_sort | predicting active site residue annotations in the pfam database |
topic | Database |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025603/ https://www.ncbi.nlm.nih.gov/pubmed/17688688 http://dx.doi.org/10.1186/1471-2105-8-298 |
work_keys_str_mv | AT mistryjaina predictingactivesiteresidueannotationsinthepfamdatabase AT batemanalex predictingactivesiteresidueannotationsinthepfamdatabase AT finnrobertd predictingactivesiteresidueannotationsinthepfamdatabase |